Paper Details
- Home
- Paper Details
Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability.
Author: ChenHuan, ChenLiang, LiJian, LiuHong, LuoRong-Hua, MaDakota, PengPanfeng, WangJiang, XieXiong, YangLiu-Meng, ZhangShurui, ZhengChang-Bo, ZhengYong-Tang, ZhengYu-Gui
Original Abstract of the Article :
Blocking the entry of an HIV-1 targeting CCR5 coreceptor has emerged as an attractive strategy to develop HIV therapeutics. Maraviroc is the only CCR5 antagonist approved by FDA; however, serious side effects limited its clinical use. Herein, 21 novel tropane derivatives (<b>6-26</b>) were designed ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1021/acs.jmedchem.2c01383
データ提供：米国国立医学図書館（NLM）
Structure-Based Design of Tropane Derivatives as CCR5 Antagonists for Anti-HIV-1 Activity
This research explores the development of new CCR5 antagonists, a class of drugs that block the entry of HIV-1 into cells. Imagine a desert fortress with a single gate, the only entry point for invaders. This study investigates how to create new, more effective keys to lock this gate, preventing HIV-1 from entering and causing infection. The researchers designed and synthesized 21 novel tropane derivatives, two of which showed promising antiviral activity, comparable to the current standard drug, maraviroc, and even exhibited synergistic or additive effects when combined with other antiretroviral agents. Additionally, these compounds showed improved oral bioavailability, making them potentially better drug candidates for treating HIV-1 infection.
New Hope for HIV-1 Treatment: Tropane Derivatives as CCR5 Antagonists
The study suggests that these novel tropane derivatives hold promise as effective CCR5 antagonists for treating HIV-1 infection. It’s like discovering a new, more secure lock for the desert fortress, further strengthening the defenses against invasion. This discovery may lead to the development of new, potentially more effective treatments for HIV-1 infection.
Understanding HIV-1 Treatment Options
If you are living with HIV-1, it’s crucial to work closely with your doctor to understand the available treatment options and choose the best approach for your individual needs. This involves adhering to a strict medication regimen and making healthy lifestyle choices. It’s like navigating a desert landscape: staying on the right path is essential for maintaining a healthy and fulfilling life.
Dr.Camel's Conclusion
This research represents a significant advancement in the fight against HIV-1 infection, offering a new avenue for developing more effective and accessible treatments. It’s like discovering a new, hidden oasis in a vast desert, providing a source of hope and potential for a healthier future.
Date :
- Date Completed 2022-12-23
- Date Revised 2023-01-05
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.